ϸ°ûÉúÎïѧµÚËİ棨µÔÖкÍÍõϲÖÒ¶¡Ã÷Т£©Ãû´Ê½âÊÍ

ÖÐÎÄ °©»ùÒò °±õ£-tRNAºÏ³Éø °µ·´Ó¦

°×½éËØ-1¦Âת»»Ã¸ °ëÇÅÁ£ °û¼äÁ¬Ë¿ °ûÄÚÌå °ûÍÂ×÷Óà °ûÍÌ×÷Óà °ûÍâ»ùÖÊ °ûÖʶ¯Á¦µ°°× °ûÖÊ·ÖÁÑ ±í¹ÛÒÅ´« ²¡¶¾Á£×Ó ²¶¹â¸´ºÏÌå¢ò ²ÚÃæÄÚÖÊÍø ³£È¾É«ÖÊ ³ÉĤÌå ³ÌÐòÐÔϸ°ûËÀÍö ³õÉú±Ú

Ó¢ÎÄ

oncogene

aminoacyl tRNA synthetase

½âÊÍ

ͨ³£±íʾԭ°©»ùÒò£¨proto oncogene£©µÄÍ»±äÌ壬ÕâЩ»ùÒò±àÂëµÄµ°°×ʹϸ°ûµÄÉú³¤Ê§È¥¿ØÖÆ£¬²¢×ª±ä³É°©Ï¸°û£¬¹Ê³Æ°©»ùÒò¡£ ½«°±»ùËáºÍ¶ÔÓ¦µÄtRNAµÄ3¡ä¶Ë½øÐй²¼ÛÁ¬½ÓÐγɰ±õ£-tRNAµÄø¡£²»Í¬µÄ°±»ùËá±»²»Í¬µÄ°±õ££­tRNAºÏ³ÉøËùʶ±ð¡£ ¹âºÏ×÷ÓÃÖеÄÁíÍâÒ»ÖÖ·´Ó¦£¬ÓÖ³ÆÌ¼Í¬»¯·´Ó¦£¨carbon

assimilation reaction)¡£¸Ã·´Ó¦ÀûÓùⷴӦÉú³ÉµÄATPºÍNADPHÖеÄÄÜÁ¿£¬¹Ì¶¨CO2Éú³ÉÌÇÀà¡£

light independent reaction

interleukin-1¦Â converting enzyme£¬Caspase-1£¬Caspase¼Ò×å³ÉÔ±Ö®Ò»£¬Ïß³æCed3ÔÚ²¸È鶯Îïϸ°ûÖеÄICE

hemidesmosome plasmodesma endosome exocytosis endocytosis

ͬԴµ°°×£¬´ß»¯°×½éËØ-1¦ÂǰÌåµÄ¼ôÇгÉÊì¹ý³Ì¡£

λÓÚÉÏÆ¤Ï¸°û»ùµ×ÃæµÄÒ»ÖÖÌØ»¯µÄð¤×Žṹ£¬½«Ï¸°û𤸽µ½»ùĤÉÏ¡£ ÏàÁÚÖ²Îïϸ°ûÖ®¼äµÄÁªÏµÍ¨µÀ£¬Ö±½Ó´©¹ýÁ½ÏàÁÚϸ°ûµÄϸ°û±Ú¡£ ¶¯Îïϸ°ûÄÚÓÉĤ°üΧµÄϸ°ûÆ÷£¬Æä×÷ÓÃÊÇתÔËÓɰûÍÌ×÷ÓÃÐÂÉãÈ¡µÄÎïÖʵ½ÈÜøÌå±»½µ½â¡£°ûÄÚÌå±»ÈÏΪÊǰûÍÌÎïÖʵÄÖ÷Òª·Öѡվ¡£ Я´øÓÐÄÚÈÝÎïµÄĤÅÝÓëÖÊĤÈںϣ¬½«ÄÚÈÝÎïÊͷŵ½°ûÍâµÄ¹ý³Ì¡£ ͨ¹ýÖÊĤÄÚÏÝÐγÉĤÅÝ£¬½«Ï¸°ûÍâ»òϸ°ûÖÊĤ±íÃæµÄÎïÖʰü¹üµ½Ä¤ÅÝÄÚ²¢×ªÔ˵½Ï¸°ûÄÚ£¨°ûÒûºÍÍÌÊÉ×÷Óã©¡£

·Ö²¼ÓÚϸ°ûÍâ¿Õ¼ä¡¢ÓÉϸ°û·ÖÃڵĵ°°×ÖʺͶàÌÇËù¹¹³ÉµÄÍøÂç½á¹¹£¬

extracellular matrix

È罺ԭºÍµ°°×¾ÛÌǵȣ¬ÔÚ¾ö¶¨Ï¸°ûÐÎ×´ºÍ»îÐԵĹý³ÌÖÐÆð×ÅÒ»ÖÖÕûºÏ×÷Óá£

cytoplasmic dynein cytokinesis epigenetics virion

ÓɶàÌõëÄÁ´×é³ÉµÄ¾ÞÐÍÂí´ïµ°°×£¬ÀûÓÃATPË®½âÊͷŵÄÄÜÁ¿½«Ä¤ÅÝ»òĤÐÔϸ°ûÆ÷µÈÑØÎ¢¹Ü³¯¸º¼«×ªÔË¡£

ϸ°ûÖÜÆÚµÄÒ»²¿·Ö£¬ÔÚ´ËÆÚ¼äÒ»¸öϸ°û·ÖÁÑΪÁ½¸ö×Óϸ°û¡£ ÓëºËÜÕËáÐòÁÐÎ޹صĵ÷½Ú»ùÒò±í´ïµÄ¿ÉÒÅ´«¿ØÖÆ»úÖÆ¡£

µ¥¸ö²¡¶¾¿ÅÁ££¬Í¨³£Óɵ°°×Íâ¿ÇºÍ°ü¹üÔÚÆäÄÚµÄÒÅ´«ÎïÖʹ²Í¬×é³É£¬½öÄÜÔÚËÞÖ÷ϸ°ûÄÚÔöÖ³£¬¹ã·ºÓÃÓÚϸ°ûÉúÎïѧÑо¿¡£

λÓÚ¹âϵͳ¢ñÖ®ÍâµÄÉ«ËØµ°°×¸´ºÏÎº¬ÓдóÁ¿ÌìÏßÉ«ËØÎª¹âϵͳ light harvesting complex ¢ò£¬LHC¢ò

¢ò£¨PS¢ò£©ÊÕ¼¯¹â×Ó¡£ rough endoplasmic reticulum£¬RER euchromatin phragmoplast

¸½×ÅÓкËÌÇÌåµÄÄÚÖÊÍø¡£²ÚÃæÄÚÖÊÍøÓÉÐí¶à±âƽĤÄÒ×é³É£¬Ö÷Òª¹¦ÄܰüÀ¨ºÏ³É·ÖÃÚÐÔµ°°×¡¢ÈÜøÌåµ°°×¡¢Ä¤ÕûºÏµ°°×ÒÔ¼°Ä¤Ö¬·Ö×Ó¡£ ¼äÆÚºËÖд¦ÓÚ·Öɢ״̬¡¢Ñ¹Ëõ³Ì¶ÈÏà¶Ô½ÏµÍ¡¢×ÅÉ«½ÏdzµÄȾɫÖÊ¡£ ÔÚÖ²Îïϸ°ûÖÐÆÚ³àµÀ°åÏàӦλÖÃÉÏÖÂÃÜÅÅÁеÄÎïÖÊ¡£Óɳɴؽ»´íµÄ΢¹Ü£¨Óë¼´½«ÐγɵÄϸ°û°å´¹Ö±£©ºÍһЩÓëÆäÏàÁ¬µÄµç×ÓÖÂÃÜÎï×é³É¡£

programmed cell death£¬PCD primary wall

ÊÇÊܵ½ÑϸñµÄ»ùÒòµ÷¿Ø¡¢³ÌÐòÐÔµÄϸ°ûËÀÍöÐÎʽ¡£¶ÔÉúÎïÌåµÄÕý³£·¢Óý¡¢×ÔÎÈ̬ƽºâ¼°¶àÖÖ²¡Àí¹ý³Ì¾ßÓÐÖØÒªµÄÒâÒå¡£ Éú³¤ÖеÄÖ²Îïϸ°û±Ú£¬¾ßÓпÉÉìÕ¹ÐÔ¡£

ÖÐÎÄ ´ÎÉú±Ú

Ó¢ÎÄ

secondary wall

½âÊÍ

ÔÚ´ó¶àÊý³ÉÊìÖ²Îïϸ°ûÖз¢ÏֵĽϺñµÄϸ°û±Ú¡£

´Ö¼¡Ë¿ µ¥¿Ë¡¿¹Ìå µ¨¹Ì´¼ µ°°×¼¤Ã¸ µ°°×¼¤Ã¸C µ°°×¾ÛÌÇ µ°°×øÌå µ°°×ÖÊ·ÖÑ¡ µÆË¢È¾É«Ìå µÚ¶þÐÅʹ µç»¯Ñ§ÌÝ¶È µç×Ó´«µÝÁ´

thick filament monoclonal antibody cholesterol protein kinase protein kinase C

×é³É¼¡½ÚµÄÁ½ÖÖÌØÕ÷ÐÔÏËά֮һ£¬Ö÷ÒªÓɼ¡Çòµ°°×¹¹³É¡£ÔÚºáÇÐÃæÉÏ´Ö¼¡Ë¿±»³ÊÁù½ÇÐÎÅÅÁеÄ6¸ùϸ¼¡Ë¿Ëù°üΧ¡£ À´×Ôµ¥¸öϸ°û¿Ë¡Ëù·ÖÃڵĿ¹Ìå·Ö×Ó¡£

¶¯Îïϸ°ûÄÚµÄÒ»Ö̴ֹ¼ÀàÎïÖÊ£¬Õ¼Ï¸°ûÖÊĤÖÐÖ¬ÖÊÎïÖʵİëÊýÒÔÉÏ¡£Ä¤ÄÚµ¨¹Ì´¼Ïà¶Ôº¬Á¿µÄ¸ßµÍ¿ÉÒÔÓ°ÏìĤµÄÁ÷¶¯ÐÔ¡£

½«Á×Ëá»ùÍÅ×ªÒÆµ½ÆäËûµ°°×ÖÊÉϵÄø£¬Í¨³£¶ÔÆäËûµ°°×ÖʵĻîÐÔ¾ßÓе÷½Ú×÷Óá£

Ò»Àà¶à¹¦ÄܵÄË¿°±Ëá/ËÕ°±Ëáµ°°×¼¤Ã¸¼Ò×壬¿ÉÁ×Ëữ¶àÖÖ²»Í¬µÄµ°°×Öʵ×Îï¡£

ÓÉÒ»¸öºËÐĵ°°×·Ö×ÓÓë¶à¸öÌǰ·¾ÛÌÇÁ´×é×°¶ø³ÉµÄµ°°×£­¶àÌǸ´ºÏÎï¡£µ°°×¾ÛÌÇ¿ÉÎü¸½´óÁ¿Ë®·Ö×ÓÐγÉÒ»¸ö¶à¿×µÄÇ×Ë®ÐÔÄý½º£¬¸³Óè×éÖ¯¿¹Ñ¹ÌØÐÔ¡£

ÔÚϸ°ûÖÊ»ùÖÊÖнµ½â±»·ºËرê¼Çµ°°×ÖʵĴó·Ö×Óµ°°×¸´ºÏÌå¡£ ÒÀ¿¿µ°°×ÖÊ×ÔÉíÐźÅÐòÁУ¬´Óµ°°×ÖÊÆðʼºÏ³É²¿Î»×ªÔ˵½Æä¹¦ÄÜ·¢»Ó²¿Î»µÄ¹ý³Ì¡£µ°°×ÖÊ·ÖÑ¡²»½ö±£Ö¤Á˵°°×ÖʵÄÕýÈ·¶¨Î»£¬Ò²±£Ö¤Á˵°°×ÖʵÄÉúÎïѧ»îÐÔ¡£

½ÏÆÕ±é´æÔÚÓÚÓãÀà¡¢Á½ÆÜÀàµÈ¶¯ÎïµÄÂÑĸϸ°û¼õÊý·ÖÁÑË«ÏßÆÚ£¬ÓɾßÓÐת¼»îÐÔµÄȾɫÖÊ»·ÐγÉÀàËÆµÆË¢µÄÌØÊâ¾Þ´óȾɫÌå¡£ µÚÒ»ÐÅʹ·Ö×Ó£¨¼¤ËØ»òÆäËûÅäÌ壩Óëϸ°û±íÃæÊÜÌå½áºÏºó£¬ÔÚϸ°ûÄÚ²úÉú»òÊͷŵ½Ï¸°ûÄÚµÄС·Ö×ÓÎïÖÊ£¬ÈçcAMP, IP3, CaµÈ£¬ÓÐÖúÓÚÐźÅÏò°ûÄÚ½øÐд«µÝ¡£

µçºÉºÍÈÜÖÊŨ¶È×ܵIJîÒ죬¾ö¶¨ÎïÖÊÔÚÁ½¸öÇøÓòÖ®¼äµÄÔ˶¯À©É¢ÄÜÁ¦¡£

ĤÉÏһϵÁÐÓɵç×ÓÔØÌå×é³ÉµÄµç×Ó´«µÝ;¾¶¡£ÕâЩµç×ÓÔØÌå½ÓÊܸßÄܵç×Ó£¬²¢ÔÚ´«µÝ¹ý³ÌÖÐÖð²½½µµÍµç×ÓµÄÄÜÁ¿£¬×îÖÕ½«ÊͷŵÄÄÜÁ¿ÓÃÓںϳÉATP»òÒÔÆäËûÄÜÁ¿ÐÎʽ´¢´æ¡£

µòÍö·Ö×ÓApaf-1Óëϸ°ûÉ«ËØcÐγɵĸ´ºÏÌ壬Ïà¶Ô·Ö×ÓÖÊÁ¿Îª

2+

proteoglycan proteasome protein sorting

lampbrush chromosome

second messenger

electrochemical gradient

electron transport chain

µòÍö¸´ºÏÌå apoptosome

(700~1400)¡Á10£¬Ï¸°ûÖÊÖÐCaspase-9µÄǰÌå±»ÕÐļµ½¸´ºÏÌåÉϲ¢·¢Éú×ÔÉíÇиî»î»¯£¬ÒýÆðϸ°ûµòÍö¡£

ϸ°ûµòÍö¹ý³ÌÖжÏÁѵÄDNA»òȾɫÖÊÓëϸ°ûÆäËûÄÚº¬ÎïÒ»Æð±»·´ÕÛ

3

µòÍöСÌå ¶¯Á£ ¶¯×÷µçλ ¶ËÁ£ ¶ËÁ£Ã¸ ¶à¾ÛºËÌÇÌå

apoptotic body

µÄϸ°ûÖÊĤ°ü¹ü£¬ÐγɵÄÔ²ÐÎСÌå¡£µòÍöСÌå±»ÁÚ½üϸ°ûʶ±ð²¢ÍÌÊÉ¡£

λÓÚ×ÅË¿Á£Íâ±íÃæ¡¢Óɵ°°×ÖÊÐγɵĽṹ£¬ÊÇ·Ä´¸Ìå΢¹ÜµÄ¸½×Åλµã¡£

ÔÚÉñ¾­Ôª»ò¼¡Ï¸°ûÖÊĤÉϲúÉúµÄÒ»ÖÖ¿ìËÙ¡¢¶ÌÔÝ¡¢×ÔÎÒ´«²¥µÄµçÐźš£¶¯×÷µçλ»òÕßÉñ¾­³å¶¯ÊÇÉñ¾­ÏµÍ³Í¨Ñ¶µÄ»ù´¡¡£

λÓÚȾɫÌåÄ©¶ËµÄÖØ¸´ÐòÁУ¬¶ÔȾɫÌå½á¹¹Îȶ¨¡¢Ä©¶Ë¸´ÖƵÈÓÐÖØÒª×÷Ó᣶ËÁ£³£ÔÚÿÌõȾɫÌåÄ©¶ËÐγÉÒ»¶¥¡°Ã±×Ó¡±½á¹¹¡£ º¬ÓÐRNAµÄ·´×ªÂ¼Ã¸£¬ÄÜÒÔ×ÔÉíRNAΪģ°å£¬¶ÔDNA¶ËÁ£ÐòÁнøÐÐÑÓ³¤¶ø½â¾öÏßÐÔȾɫÌåÄ©¶Ë¸´ÖÆÎÊÌâ¡£

Óɶà¸öÉõÖÁ¼¸Ê®¸öºËÌÇÌå´®ÁªÔÚÒ»ÌõmRNA·Ö×ÓÉϽøÐÐëÄÁ´ºÏ³ÉµÄºËÌÇÌåÓëmRNAµÄ¾ÛºÏÌå¡£

kinetochore action potential telomere telomerase

polyribosome, polysome

ÖÐÎÄ ¶àÏßȾɫÌå

Ó¢ÎÄ

polytene chromosome

½âÊÍ

ȾɫÌåDNA¾­¶à´Î¸´Öƶø²»·Ö¿ª¡¢³Ê¹æÔò²¢Åŵľ޴óȾɫÌ壬À¥³æÖеľ޴óȾɫÌåÐÎÌ¬ÌØÕ÷×îΪµäÐÍ¡£

´¦Óڸ߶û»ùÌå·´ÃæµÄ¹ÜÍø×´½á¹¹£¬Ö÷Òª¹¦ÄÜÊǸºÔð¶Ôµ°°×ÖʽøÐзÖÑ¡£¬²¢¶¨Ïò½«µ°°×ÖÊתÔ˵½Ï¸°ûÄÚ»òϸ°ûÍâµÄ×îÖÕλÖᣠ¶ÔÆäÒÆ¶¯ÐèÒª·´×ªÂ¼Ã¸µÄת×ùÔª¼þ¡£

ÕæºËϸ°ûÖи߶ȱ£ÊصÄС·Ö×Óµ°°×£¬ÓëÒª½µ½âµÄµ°°×ÖʵÄÀµ°±Ëá²Ð»ù¹²¼ÛÁ¬½Ó£¬Ö¸µ¼µ°°×ÖÊÔÚµ°°×øÌåÖнøÐнµ½â¡£

ÔÚE1¡¢E2¡¢E3ÈýÖÖøµÄ´ß»¯Ï£¬Í¨¹ýһϵÁм¶Áª·´Ó¦½«·ºËØÁ¬½Óµ½°Ðµ°°×ÉÏ£¬×îºóÓÉ26Sµ°°×øÌåÌØÒìÐÔʶ±ð±»·ºËØ»¯µÄµ×Îï²¢½«Æä½µ½â£¬Í¬Ê±Êͷųö·ºËص¥ÌåÒÔ±¸Ñ­»·ÀûÓá£

ͨ¹ý¼ì²â·ÅÉäÐÔ±ê¼ÇÎïÖÊÔÚϸ°ûÄڵĶ¨Î»À´¹Û²ìÄ³Ò»ÌØ¶¨Éú»¯·´Ó¦¹ý³ÌµÄ¼¼Êõ¡£ÔÚº¬ÓзÅÉäÐÔÍ¬Î»ËØµÄ×éÖ¯ÇÐÆ¬ÉÏͿһ±¡²ã¸Ð¹âÈ齺£¬È齺¾­×éÖ¯·¢³öµÄÉäÏßÆØ¹â¡¢ÏÔÓ°,ÔÚÏÔ΢¾µÏÂͨ¹ý¹Û²ìÒø¿ÅÁ£¶¨Î»£¬¿ÉÒÔ»ñ֪ϸ°ûÖÐÓзÅÉäÐÔÐźŵÄλµã¡£

ÔÚ¹âºÏ×÷ÓùⷴӦÖÐÐγÉATPµÄ¹ý³Ì£¬ÆäÖеç×Ó´ÓH2O·Ö×Óµ½NADP£«³ÊÏßÐÔ´«µÝ¡£

ÏÔ΢¾µÄÜÇø·Ö¿ªÁ½¸öÖʵã¼äµÄ×îС¾àÀ룬¹«Ê½ÎªD=0.61¦Ë£¯£ÛNsin(¦Á/2)£Ý£¬ÆäÖÐDÊÇÑùÆ·ÖпÉÒÔ±»·Ö±æ¿ªÀ´µÄÁ½Öʵã¼äµÄ×îС¾àÀ룬¦ËÊÇÕÕÉä¹âµÄ²¨³¤£¬NÊǽéÖʵÄÕÛÉäÂÊ£¬¦Á´ú±í͸¾µµÄ¾µ¿Ú½Ç£¬Óë͸¾µ¿×¾¶´óСֱ½ÓÏà¹Ø¡£

¾­ÄÚÖÊÍø¡¢¸ß¶û»ùÌ嵽ϸ°û±íÃæ¡¢ÈÜøÌå»òÖ²Îïϸ°ûÒºÅݵȵÄÎïÖÊ

·´Ãæ¸ß¶û»ùÌå¹ÜÍø×´½á

trans Golgi network£¬TGN

¹¹

·´×ªÂ¼×ª×ù×Ó ·ºËØ

retrotransposons ubiquitin

·ºËØÒÀÀµÐÔ½µ½â;¾¶ ubiquitin dependent pathway

·ÅÉä×ÔÏÔÓ°¼¼Êõ autoradiography

·ÇÑ­»·¹âºÏÁ×Ëữ noncyclic photophosphorylation

·Ö±æÂÊ limit of resolution

·ÖÃÚ;¾¶ ·Ö×Ó°é ·Ö×Ó¿ª¹Ø ·â±ÕÁ¬½Ó ¸ºÈ¾É« ¸Æ±Ã ¸Æð¤µ°°× ¸Æµ÷µ°°× ¸Ê¶ÌÇ-6-Á×Ëá ¸Éϸ°û

secretory pathway

·ÖÃÚ·¾¶¡£ÆäÖÐÉæ¼°·ÖÃÚÎïµÄºÏ³É¡¢ÐÞÊκͷÖÃÚÎïÍâÅŵȹý³Ì¡£¸Ã¹ý³Ì°üÀ¨×é³ÉÐÍ·ÖÃںͿɵ÷¿ØÐÍ·ÖÃÚ¡£

Ò»ÖÖÓëÆäËû¶àëÄ»òµ°°×ÖʽáºÏµÄµ°°×ÖÊ£¬ÒÔ·ÀÖ¹µ°°×ÖÊ´íÎóÕÛµþ¡¢±äÐÔ»ò¾Û¼¯³Áµí£¬¶Ôµ°°×ÖʵÄÕýÈ·ÕÛµþ¡¢×é×°ÒÔ¼°¿çĤתÔËÓÐÒâÒå¡£ ϸ°ûÐźÅתµ¼¹ý³ÌÖУ¬Í¨¹ý½áºÏGTPÓëË®½âGTP£¬»òÕßͨ¹ýµ°°×ÖÊÁ×ËữÓëÈ¥Á×Ëữ¶ø¿ªÆô»ò¹Ø±Õµ°°×ÖʵĻîÐÔ¡£

½«ÏàÁÚÉÏÆ¤Ï¸°ûµÄÖÊĤ½ôÃܵØÁ¬½ÓÔÚÒ»Æð£¬×èÖ¹ÈÜÒºÖеÄС·Ö×ÓÑØÏ¸°û¼ä϶´Óϸ°ûÒ»²àÉøÍ¸µ½ÁíÒ»²à¡£½ôÃÜÁ¬½ÓÊÇÕâÖÖÁ¬½ÓµÄµäÐÍ´ú±í¡£

ÓÃÖØ½ðÊôÑζԵ羵ÑùÆ·½øÐÐȾɫµÄ¼¼Êõ£¬Ê¹µÃÖØ½ðÊôÑγÁ»ýÔÚÑùÆ·ÖÜΧ£¬¶øÑùÆ·²»±»È¾É«£¬´Ó¶ø³ÄÍгöÑùÆ·µÄ¾«Ï¸½á¹¹¡£ ÔÚ¼¡Ï¸°ûµÄ¼¡ÖÊÍøÄ¤ÉϺ¬Á¿·á¸»µÄ¿çĤתÔ˵°°×£¬ÊôÓÚPÐͱã¬ÀûÓÃATPË®½âÊͷŵÄÄÜÁ¿½«Ca´Óϸ°ûÖÊ»ùÖʱõ½¼¡ÖÊÍøÄÚ¡£

2+

chaperone£¬molecular chaperon molecular switch

occluding junction

negative staining calcium pump£¬Ca-ATPase

2+

cadherin calmodulin

mannose-6-phosphate, M6P stem cell

½éµ¼CaÒÀÀµÐÔµÄϸ°ûÓëϸ°û¼äð¤×ŵÄÏà¹ØÌǵ°°×¼Ò×å³ÉÔ±¡£

2+

Ò»Öָ߶ȱ£ÊØ¡¢¹ã·º·Ö²¼µÄС·Ö×ÓCa½áºÏµ°°×£¬²ÎÓëÐí¶àCa+ÒÀÀµÐÔµÄÉúÀí·´Ó¦ÓëÐźÅתµ¼¡£Ã¿¸ö¸Æµ÷µ°°×·Ö×ÓÓÐ4¸ö¸ÆÀë×Ó½áºÏλµã¡£

ÈÜøÌ帵ĹÑÌÇÁ´¸Ê¶ÌDzлù±»Á×ËữÐγɵÄÒ»¸ö·ÖÑ¡±ê¼Ç¡£ ·Ö»¯³Ì¶ÈÏà¶Ô½ÏµÍ¡¢¾ßÓв»¶ÏÔöÖ³ºÍ·Ö»¯ÄÜÁ¦µÄϸ°û¡£

2+2+

¸ß¶û»ù¸´ºÏÌå ¹²¾Û½¹É¨ÃèÏÔ΢¾µ

Golgi complex

confocal sanning microscope

Ò»ÖÖÓɹÜÍø½á¹¹ºÍ¶à¸öĤÄÒ×é³ÉµÄ¼«ÐÔϸ°ûÆ÷£¬Ö÷Òª¹¦ÄÜÊǶÔERתÔËÀ´µÄÖ¬·Ö×Ó¼°µ°°×ÖʽøÐмӹ¤¡¢ÐÞÊÎÒÔ¼°·ÖÑ¡¡£

Óþ۽¹¼«ºÃµÄ¼¤¹âÊø¶ÔÑùÆ·µ¥Ò»¾°ÉîµÄ²ãÃæ½øÐпìËÙɨÃ裬´Ó¶ø»ñµÃ¡°¹âѧÇÐÆ¬¡±Ð§¹ûµÄÏÔ΢¾µ¡£

ÖÐÎÄ ¹â·´Ó¦ ¹âÃæÄÚÖÊÍø ¹âϵͳ ¹ýÑõ»¯ÎïøÌå ºË±»Ä¤ ºË»ùÖÊ ºË¿×¸´ºÏÌå ºËø ºËÄÚСRNA

Ó¢ÎÄ

light dependent reaction

½âÊÍ

¹¹³É¹âºÏ×÷ÓõÄÁ½ÖÖ·´Ó¦Ö®Ò»¡£¸Ã·´Ó¦½«ÎüÊÕµÄÌ«Ñô¹âÄÜת»¯³É»¯Ñ§ÄÜ£¬´¢´æÔÚATPºÍNADPHÖС£

ûÓи½×źËÌÇÌåµÄÄÚÖÊÍø²¿·Ö¡£¹âÃæÄÚÖÊÍø³Ê·ÖÖ§¹Ü×´£¬¹¦ÄܰüÀ¨

smooth endoplasmic reticulum£¬SER Àà¹Ì´¼¼¤Ëصĺϳɡ¢ÓлúÎïµÄ½â¶¾¡¢½«ÆÏÌÑÌÇ-6-Á×ËáѸËÙת»¯³ÉÆÏ

ÌÑÌÇÒÔ¼°CaµÄ´¢´æµÈ¡£

2+

photosystem peroxisome nuclear envelope nuclear matrix

nuclear pore complex£¬NPC ribozyme

small nuclear RNA£¬snRNA

ÔÚ¹âºÏ×÷ÓÃÖÐÄܹ»ÀûÓùâÄܲ¢½«Æäת±ä³ÉÆäËûÄÜÁ¿ÐÎʽµÄ¶à¾Ûµ°°×¸´ºÏÌå¡£

ÕæºËϸ°ûÖꬶàÖÖ»îÐÔøµÄϸ°ûÆ÷¡£ÀûÓ÷Ö×ÓÑõÑõ»¯ÓлúÎï¡£ ÕæºËϸ°ûÄÚϸ°ûÖÊÓëϸ°ûºËÖ®¼äÓÉË«²ãĤ¹¹³É£¬·Ö±ð³ÆÍâºËĤÓëÄÚºËĤ¡£Ë«²ãºËĤÉÏÏâǶÓк˿׸´ºÏÌ壬ÄÜÑ¡ÔñÐÔµØÔËÊäºËÄÚÍâÎïÖÊ¡£ ϸ°ûºËÄÚ¿¹³éÌáµÄ²»ÈÜÐÔÏËÎ¬Íø×´½á¹¹¡£

ÏâǶÔÚÄÚÍâºËĤÉϵÄÀº×´¸´ºÏÌå½á¹¹£¬Ö÷ÒªÓɰûÖÊ»·¡¢ºËÖÊ»·¡¢ºËÀºµÈ½á¹¹Óò×é³É£¬ÊÇÎïÖʽø³öϸ°ûºËµÄͨµÀ¡£ ¾ßÓд߻¯×÷ÓõÄRNA·Ö×Ó¡£

RNA¼Ó¹¤¹ý³ÌÖÐËù±ØÐèµÄС·Ö×ÓRNA£¨90~300 bp£©£¬ËüÃÇÔÚϸ°ûºËÖÐÆð×÷Óá£

¼ô½ÓÌåÖи÷ÖÖºËÌǺ˵°°×¿ÅÁ£¡£ÒòÆäÓÉsnRNAsÓëÌØÒìµ°°×ÖʽáºÏ¶ø ×é³É£¬¹Ê³ÆsnRNPs¡£

ϸ°ûºËÄÚrRNAת¼¼°¼Ó¹¤²úÉúºËÌÇÌåÑÇ»ùµÄ½á¹¹£¬Æä¹¹³É°üÀ¨ÏËάÖÐÐÄ¡¢ÖÂÃÜÏËά×é·ÖºÍ¿ÅÁ£×é·Ö¡£

ÓÉÊýÖÖrRNAºÍ50¶àÖÖºËÌÇÌåµ°°××é³ÉµÄ´ó·Ö×Ó¸´ºÏÎ¾ßÓÐÒ»¸ö´óÑÇ»ùºÍÒ»¸öСÑÇ»ù£¬Êǵ°°×Öʺϳɵĵط½¡£

±àÂërRNAµÄDNAÐòÁУ¬³£³£Öظ´¼¸°Ù´Î£¬²¢´Ø¼¯ÓÚ»ùÒò×éµÄÒ»¸ö»ò¼¸¸öÇøÓò¡£

λÓÚºËĤÄڲ࣬ÓɺËÏ˲㵰°××é³ÉµÄÏËÎ¬×´ÍøÂç½á¹¹¡£ ÓÉDNAºÍ×éµ°°×ÐγɵÄȾɫÖÊ»ù±¾½á¹¹µ¥Î»¡£Ã¿¸öºËСÌåÓÉ147 bpµÄDNA ²øÈÆ×éµ°°×°Ë¾ÛÌå½üÁ½È¦Ðγɡ£ºËСÌåºËÐÄ¿ÅÁ£Ö®¼äͨ¹ý60 bp×óÓÒµÄÁ¬½ÓDNAÏàÁ¬¡£

ȾɫÌå×éÔÚÓÐË¿·ÖÁÑÖÐÆÚµÄ±íÐÍ£¬°üÀ¨È¾É«ÌåÊýÄ¿¡¢´óС¡¢ÐÎÌ¬ÌØÕ÷µÄ×ܺ͡£

ÓÐË¿·ÖÁÑÖнãÃÃȾɫµ¥Ìå·ÖÀë²¢²úÉúÏò¼«Ô˶¯µÄʱ¶Î£¬ÓɺóÆÚA£¨anaphase A£©¼°ºóÆÚB£¨anaphase B£©×é³É¡£ºóÆÚAÊÇÓÐË¿·ÖÁÑÖÐȾɫÌåÀ­ÏòÁ½¼«µÄÏò¼«Ô˶¯£¬ºóÆÚBÊÇ·Ä´¸ÌåÁ½¼«½øÒ»²½Ô¶Àë¡£ ·ºËØÁ¬½Óø£¬Í¨¹ý·ºËØÒÀÀµÐÔµ°°×½µ½â;¾¶£¬½µ½â²ÎÓë½ãÃÃȾɫµ¥Ìå·ÖÀëµÄµ°°×ÖÊ£¬Ê¹Ï¸°û´ÓÖÐÆÚÏòºóÆÚת»»¡£

ºËÄÚСºËÌǺ˵°°×¿ÅÁ£ snRNPs ºËÈÊ ºËÌÇÌå ºËÌÇÌåDNA ºËÏ˲㠺ËСÌå ºËÐÍ ºóÆÚ

ºóÆÚ´Ù½ø¸´ºÏÌå

nucleolus ribosome rDNA

nuclear lamina nucleosome

karyotype

anaphase

anaphase promoting complex£¬APC

ÁªÏµ¿Í·þ£º779662525#qq.com(#Ìæ»»Îª@)